X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Effect of conjugated estrogens and bazedoxifene on glucose, energy and lipid metabolism in obese postmenopausal women.

Kara L Marlatt | Dragana Lovre | Robbie A Beyl | Chandra R Tate | Evelyn K Hayes | Charles F Burant | Eric Ravussin | Franck Mauvais-Jarvis
European journal of endocrinology | 2020

Combining conjugated estrogens (CE) with the selective estrogen receptor modulator bazedoxifene (BZA) is a novel, orally administered menopausal therapy. We investigated the effect of CE/BZA on insulin sensitivity, energy metabolism, and serum metabolome in postmenopausal women with obesity.

Pubmed ID: 32698159 RIS Download

Associated grants

  • Agency: BLRD VA, United States
    Id: I01 BX003725
  • Agency: NIDDK NIH HHS, United States
    Id: T32 DK064584
  • Agency: NICHD NIH HHS, United States
    Id: K12 HD043451
  • Agency: NIGMS NIH HHS, United States
    Id: U54 GM104940
  • Agency: NIDDK NIH HHS, United States
    Id: P30 DK089503
  • Agency: NIDDK NIH HHS, United States
    Id: R01 DK107444
  • Agency: NIDDK NIH HHS, United States
    Id: R01 DK074970
  • Agency: NIDDK NIH HHS, United States
    Id: P30 DK072476

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.